-
Study aim
-
Determining the effect of adding sublingual desmopressin to intravenous treatment with Apotel and ketorolac in patients with mild to moderate renal colic pain.
Using the results and information of this study to measure the effectiveness of desmopressin in controlling the pain of renal colic and reducing the amount of pain while having fewer and cheaper side effects is the availability of desmopressin.
-
Design
-
A controlled, parallel-group, unblinded, randomized, phase 3 clinical trial on 102 randomized sealed envelopes.
-
Settings and conduct
-
Clinical trial on the effect of desmopressin in renal colic, emergency department of Imam Khomeini hospital in Ahvaz and emergency department of Golestan hospital in Ahvaz, patients who have renal colic and meet the inclusion criteria are randomly selected into two intervention and control groups, and desmopressin intervention group It will be given
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: All patients with renal colic who have not received painkillers in the last three hours and are not suffering from high blood pressure, coronary artery disease, gastric ulcer, kidney failure and liver failure and are not taking anticoagulant treatment and are not pregnant.
-
Intervention groups
-
In group A (control), apotel 1g and ketorolac 30mg are injected, and group B (intervention) apotel 1g and ketorolac 30mg are injected, and a sublingual tablet of desmopressin is placed under the patient's tongue.
-
Main outcome variables
-
Determining the amount of pain in control and intervention group at times zero, 15m , 30m , 45 m ,60m and comparing them
comparison of pain reduction time in intervention and control group
comparison the speed of pain reduction in intervention and control group
Determining of complications in control and intervention group and comparing them